These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70. Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids. Baek CH; Kim CD; Lee DR; Kim YH; Yang J; Kim BS; Lee JS; Han SY; Kim SW; Lee S; Lee KW; Kong JM; Shin BC; Lee SH; Chae DW; Kwon YJ; Jiang H; Lee H; Park SK Transplant Proc; 2019 Apr; 51(3):749-760. PubMed ID: 30979460 [TBL] [Abstract][Full Text] [Related]
71. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Jardine AG Transpl Int; 2005 Apr; 18(4):379-84. PubMed ID: 15773954 [TBL] [Abstract][Full Text] [Related]
72. Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials. Sommerer C; Witzke O; Lehner F; Arns W; Reinke P; Eisenberger U; Vogt B; Heller K; Jacobi J; Guba M; Stahl R; Hauser IA; Kliem V; Wüthrich RP; Mühlfeld A; Suwelack B; Duerr M; Paulus EM; Zeier M; Porstner M; Budde K; BMC Nephrol; 2018 Sep; 19(1):237. PubMed ID: 30231851 [TBL] [Abstract][Full Text] [Related]
73. Influence of Calcineurin Inhibitor and Sex on Mycophenolic Acid Pharmacokinetics and Adverse Effects Post-Renal Transplant. Meaney CJ; Sudchada P; Consiglio JD; Wilding GE; Cooper LM; Venuto RC; Tornatore KM J Clin Pharmacol; 2019 Oct; 59(10):1351-1365. PubMed ID: 31062373 [TBL] [Abstract][Full Text] [Related]
74. Safety and Effectiveness of Conversion From Cyclosporine to Once-Daily Prolonged-Release Tacrolimus in Stable Kidney Transplant Patients: A Multicenter Observational Study in Japan. Usuki S; Uno S; Sugamori H; Tanaka H; Aikawa A Transplant Proc; 2018 Dec; 50(10):3266-3274. PubMed ID: 30577196 [TBL] [Abstract][Full Text] [Related]
75. Associations of ECG interval prolongations with mortality among ESRD patients evaluated for renal transplantation. Flueckiger P; Pastan S; Goyal A; McClellan WW; Patzer RE Ann Transplant; 2014 May; 19():257-68. PubMed ID: 24878746 [TBL] [Abstract][Full Text] [Related]
76. [Prolonged QTc intervals in Parkinson's disease--relation to sudden death and autonomic dysfunction]. Ishizaki F; Harada T; Yoshinaga H; Nakayama T; Yamamura Y; Nakamura S No To Shinkei; 1996 May; 48(5):443-8. PubMed ID: 8672303 [TBL] [Abstract][Full Text] [Related]
77. The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria. Barone GW; Gurley BJ; Anderson KE; Ketel BL; Abul-Ezz SR J Clin Pharmacol; 2001 Jan; 41(1):113-5. PubMed ID: 11144989 [TBL] [Abstract][Full Text] [Related]
78. Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study. Tedesco-Silva H; Pascual J; Viklicky O; Basic-Jukic N; Cassuto E; Kim DY; Cruzado JM; Sommerer C; Adel Bakr M; Garcia VD; Uyen HD; Russ G; Soo Kim M; Kuypers D; Buchler M; Citterio F; Hernandez Gutierrez MP; Bernhardt P; Chadban S; Transplantation; 2019 Sep; 103(9):1953-1963. PubMed ID: 30801548 [TBL] [Abstract][Full Text] [Related]
79. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation. Batista F; Auyanet I; Torregrosa JV; Oppenheimer F Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461 [TBL] [Abstract][Full Text] [Related]
80. Changes in QTc interval in long-term hemodialysis patients. Matsumoto Y; Mori Y; Kageyama S; Arihara K; Sato H; Nagata K; Shimada Y; Nojima Y; Iguchi K; Sugiyama T PLoS One; 2019; 14(1):e0209297. PubMed ID: 30605455 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]